The SSA & The Australasian Society of Thrombosis and Haemostasis (ASTH) have both endorsed guidelines to enable the safe use of stroke thrombolysis in the context of those stroke patients being actively treated with the new direct thrombin inhibitor, dabigatran. SSA members please
click here to view the guidelines.